🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
To learn if the drug combination of tiragolumab and ivonescimab can help to...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-07-28
Trial ID
NCT07038915
Treatments Being Tested
The object of this trial is to test whether ivonescimab is superior to stan...
Status
Recruiting
Location
CHU Amiens Picardie
Start Date
2025-10-09
Trial ID
NCT06529718
Treatments Being Tested
This study aims to evaluate the safety and efficacy of Ivonescimab, a bispe...
Status
Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2025-02-08
Trial ID
NCT06844422
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
This is a single-arm, open-label, Phase Ib/II clinical trial designed to ev...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-30
Trial ID
NCT06957561
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06620796
Treatments Being Tested
This study is a single-center, prospective, single-arm clinical trial, whic...
Status
Recruiting
Location
Fudan University Shanghai Cancer center
Start Date
2024-12-17
Trial ID
NCT06793332
Treatments Being Tested
This study evaluates the safety, tolerability, maximum tolerated dose (MTD)...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-01
Trial ID
NCT07339839
Treatments Being Tested
This study is a single-center, open-label Phase II clinical trial, aiming t...
Status
Unknown
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2024-03-14
Trial ID
NCT06375486
Treatments Being Tested